JMKX 000197
Alternative Names: JMKX-000197Latest Information Update: 05 Jan 2024
At a glance
- Originator Jemincare
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Malignant pleural effusion
- Preclinical Bladder cancer
- Research Head and neck cancer